Found: 16
Select item for more details and to access through your institution.
The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 19, p. 7358, doi. 10.3390/ijms21197358
- By:
- Publication type:
- Article
Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5278, doi. 10.3390/ijms21155278
- By:
- Publication type:
- Article
Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive–like behaviors in mice.
- Published in:
- Nature Medicine, 2010, v. 16, n. 5, p. 598, doi. 10.1038/nm.2125
- By:
- Publication type:
- Article
Prominin 1/CD133 Endothelium Sustains Growth of Proneural Glioma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0062150
- By:
- Publication type:
- Article
Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement.
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2890-0
- By:
- Publication type:
- Article
Using EGFR amplification to stratify recurrent glioblastoma treated with immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1893, doi. 10.1007/s00262-023-03381-y
- By:
- Publication type:
- Article
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas†.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 11, p. 1244, doi. 10.1093/neuonc/nor117
- By:
- Publication type:
- Article
YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma.
- Published in:
- Annals of Neurology, 2011, v. 70, n. 1, p. 163, doi. 10.1002/ana.22360
- By:
- Publication type:
- Article
Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment.
- Published in:
- British Journal of Haematology, 2004, v. 126, n. 2, p. 202, doi. 10.1111/j.1365-2141.2004.05028.x
- By:
- Publication type:
- Article
Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 128, n. 2, p. 241, doi. 10.1007/s11060-016-2101-5
- By:
- Publication type:
- Article
Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 106, n. 1, p. 15, doi. 10.1007/s11060-011-0672-8
- By:
- Publication type:
- Article
Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.
- Published in:
- Journal of Neuro-Oncology, 2011, v. 105, n. 3, p. 607, doi. 10.1007/s11060-011-0628-z
- By:
- Publication type:
- Article
Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas.
- Published in:
- Journal of Neuro-Oncology, 2008, v. 88, n. 3, p. 293, doi. 10.1007/s11060-008-9563-z
- By:
- Publication type:
- Article
A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2008, v. 87, n. 1, p. 85, doi. 10.1007/s11060-007-9491-3
- By:
- Publication type:
- Article
Uveomeningoencephalitis in a human immunodeficiency virus type 2-seropositive patient.
- Published in:
- Annals of Neurology, 1988, v. 23, n. 3, p. 308, doi. 10.1002/ana.410230318
- By:
- Publication type:
- Article
Letters to the editor.
- Published in:
- Muscle & Nerve, 1993, v. 16, n. 12, p. 1415, doi. 10.1002/mus.880161221
- By:
- Publication type:
- Article